Sectoral Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Sectoral Asset Management Inc

$120 Million
Q3 2024

A detailed history of Sectoral Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 3,400 shares of REGN stock, worth $2.3 Million. This represents 2.98% of its overall portfolio holdings.

Number of Shares

3,400

Previous 6,040 43.71%

Holding current value

$2.3 Million

Previous $6.35 Million 43.7%

% of portfolio

2.98%

Previous 3.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $2.7 Million - $3.17 Million	-2,640 Reduced 43.71%	3,400 $3.57 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $914,112 - $1.11 Million	-1,035 Reduced 14.63%	6,040 $6.35 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $2.92 Million - $3.22 Million	3,240 Added 84.49%	7,075 $6.81 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $89,145 - $101,395	115 Added 3.09%	3,835 $3.37 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $362,843 - $442,449	524 Added 16.4%	3,720 $3.06 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $284,212 - $337,122	406 Added 14.55%	3,196 $2.3 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $54,439 - $66,157	80 Added 2.95%	2,790 $2.29 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $430,592 - $467,497	-610 Reduced 18.37%	2,710 $1.96 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $63,136 - $79,675	110 Added 3.43%	3,320 $2.29 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $93,219 - $125,602	170 Added 5.59%	3,210 $1.9 Million
Q1 2022 May 10, 2022	SELL	$595.12 - $698.43 $220,194 - $258,419	-370 Reduced 10.85%	3,040 $2.12 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $168,478 - $208,000	-310 Reduced 8.33%	3,410 $2.15 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $287,015 - $340,480	-500 Reduced 11.85%	3,720 $2.25 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $189,120 - $223,416	-400 Reduced 8.66%	4,220 $2.36 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $8.76 Million - $11.1 Million	-18,310 Reduced 79.85%	4,620 $2.23 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $2.66 Million - $3.22 Million	4,892 Added 27.12%	22,930 $12.8 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $5.07 Million - $6.61 Million	10,268 Added 132.15%	18,038 $11.2 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $2.61 Million - $3.84 Million	7,770 New	7,770 $3.79 Million
Q4 2018 Feb 12, 2019	SELL	$335.82 - $403.04 $460,073 - $552,164	-1,370 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $481,061 - $559,658	1,370 New	1,370 $554,000
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $12.4 Million - $15.5 Million	-39,316 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $2.29 Million - $3.01 Million	6,399 Added 19.44%	39,316 $14.8 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $14.2 Million - $16.6 Million	32,917	32,917 $14.7 Million

Others Institutions Holding REGN

# of Institutions

1,497

Shares Held

82.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account

Sectoral Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History